China Biologic Produ (CBPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 89,412 | 80,300 | 76,842 | 56,308 | 64,941 |
Receivables | 16,757 | 22,048 | 22,496 | 15,871 | 12,862 |
Inventories | 71,339 | 65,819 | 62,599 | 57,569 | 52,301 |
Other current assets | 0 | 2,368 | 2,402 | 2,214 | 1,861 |
TOTAL | $183,694 | $171,968 | $166,383 | $133,919 | $132,820 |
Non-Current Assets | |||||
PPE Net | 43,330 | 39,916 | 39,932 | 39,590 | 39,512 |
Investments And Advances | 8,357 | 8,449 | 8,183 | 7,617 | 7,297 |
Intangibles | 12,008 | 12,248 | 36,209 | 36,602 | 37,039 |
Other Non-Current Assets | 1,505 | 5,781 | 6,429 | 4,643 | 4,255 |
TOTAL | $65,199 | $66,393 | $90,753 | $88,452 | $88,102 |
Total Assets | $248,893 | $238,361 | $257,136 | $222,371 | $220,922 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 11,018 | 10,955 | 18,564 | 6,108 | 3,034 |
Accounts payable and accrued liabilities | 41,168 | 31,463 | 30,595 | 27,751 | 29,192 |
Other current liabilities | 10,263 | 6,519 | 9,685 | 27,892 | 29,217 |
TOTAL | $67,822 | $60,231 | $71,159 | $73,999 | $71,446 |
Non-Current Liabilities | |||||
aiOther Non-Current Liabilities | -1,052 | -2,184 | -3,737 | -3,185 | -4,024 |
TOTAL | $2,029 | $2,187 | $4,338 | $4,423 | $4,432 |
Total Liabilities | $69,852 | $62,418 | $75,497 | $78,422 | $75,878 |
Shareholders' Equity | |||||
Shares Outstanding, K | 25,601 | 25,551 | 25,551 | 24,351 | 24,351 |
Common Shares | 3 | 3 | 3 | 2 | 2 |
Retained earnings | 73,921 | 69,286 | 78,648 | 62,048 | 55,739 |
Other shareholders' equity | 56,279 | 59,265 | 56,828 | 50,053 | 53,868 |
TOTAL | $179,041 | $175,944 | $181,639 | $143,949 | $145,044 |
Total Liabilities And Equity | $248,893 | $238,361 | $257,136 | $222,371 | $220,922 |